US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Latest News about Concludes Enrolment

Recent news which mentions Concludes Enrolment

FibroGen Concludes Dosing In Late-Stage Blood Cell Disorder Study, Sees Top-line Data In H1 2023
Tickers FGEN
Tags Small Cap Concludes Enrolment Market News
From Benzinga
Rain Therapeutics Concludes Enrolment In Late-Stage Tissue Cancer Study, Expects Topline Data In H1 2023
Tickers RAIN
Tags General Benzinga Biotech
From Benzinga
Vaxcyte Concludes Enrolment In Mid-Stage Pneumococcal Disease Study
Tickers PCVX
Tags General PCVX Biotech
From Benzinga